National Comprehensive Cancer Network

From WikiMD's WELLNESSPEDIA

National Comprehensive Cancer Network (NCCN) is a not-for-profit alliance of cancer centers in the United States. It is dedicated to improving the quality, effectiveness, and efficiency of cancer care so that patients can live better lives. The NCCN develops and communicates scientifically derived information about cancer care to the medical community, policy makers, and the public.

History[edit]

The NCCN was established in 1995 with the aim of addressing the growing need for evidence-based, consensus-driven guidelines for cancer treatment. Since its inception, the NCCN has grown to include 31 leading cancer centers across the United States. These member institutions are recognized for their scientific and clinical excellence in cancer research, diagnosis, and treatment.

Mission[edit]

The mission of the NCCN is to improve and facilitate quality, effective, efficient, and accessible cancer care so patients can live better lives. To achieve this, the NCCN focuses on research, education, and the creation of comprehensive clinical practice guidelines.

NCCN Guidelines[edit]

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) are a set of step-by-step directives that help healthcare providers make decisions about cancer care. These guidelines cover diagnosis, treatment, and management for a wide range of cancers and are updated regularly to reflect the latest research and clinical practices. They are considered the standard for clinical policy in oncology by clinicians and payors.

NCCN Categories[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.